Deltex Medical Group PLC Launch of ODMV+ system for veterinary anaesthesia
26 May 2017 - 4:01PM
RNS Non-Regulatory
TIDMDEMG
Deltex Medical Group PLC
26 May 2017
26 May 2017
Deltex Medical Group plc
("Deltex Medical", "Deltex" or "the Company")
Deltex releases ODMV+ system for veterinary anaesthesia and
critical care
Deltex Medical Group plc (AIM: DEMG), the global leader in
Oesophageal Doppler Monitoring ("ODM"), is pleased to announce the
launch of its first ODM system designed specifically for veterinary
use which has generated GBP15,000 on release from the first sale of
a system to a leading continental Europe Veterinary University.
The ODMV+ monitor is based on the CardioQ-ODM+ platform and is
accessed via the specially designed K9 probes. These probes are
designed for smaller animals such as dogs and cats and allow
multiple uses for a period of 30 days, providing an attractive per
case billing model for veterinary practices.
Deltex is planning the marketing launch of the new system for
the annual meeting of the International Veterinary Emergency and
Critical Care Symposium ('IVECCS') in Nashville, Tennessee in
September 2017. In the meantime it is promoting the system to
existing contacts.
Ewan Phillips, Deltex Medical's Chief Executive, commented:
"We are delighted to have made our first sale of the ODMV+
system simultaneously with its release. ODM is ideally suited for
use in animals who tend to have high degrees of haemodynamic
instability during surgery and in critical care.
"We have a small number of other customers already interested in
the system and expect to generate further interest after the market
launch at IVECCS at which there will be presentations from a number
of experts who have been working with Deltex on developing the
ODMV+. Our medium term goal is to develop the veterinary business
to a stage where it is sold through specialist distributors."
For further information, please contact:-
Deltex Medical Group 01243 774 837
plc investorinfo@deltexmedical.com
Nigel Keen, Chairman
Ewan Phillips, Chief
Executive
Jonathan Shaw, Group
Finance Director
Nominated Adviser &
Broker
Arden Partners plc 020 7614 5900
Chris Hardie
Financial Public Relations
IFC Advisory 0203 053 8671
Tim Metcalfe
Graham Herring
Heather Armstrong
Notes for Editors
Deltex Medical manufactures and markets haemodynamic monitoring
technologies. Deltex Medical's ODM is the only technology to
measure blood flow in the central circulation in real time.
Minimally invasive, easy to set up and quick to focus, the
technology generates a low-frequency ultrasound signal, which is
highly sensitive to changes in flow and measures them immediately.
Deltex has been the only company in the enhanced haemodynamic space
to build a robust and credible evidence base proving the clinical
and economic benefits of its core technology, ODM. Randomised,
controlled trials using Doppler have demonstrated that early fluid
management intervention will reduce post-operative complications,
reduce intensive care admissions, and reduce the length of hospital
stay.
Company goal
ODM is increasingly recognised as a standard of care for
patients undergoing major surgery and in critical care. The broader
clinical area of haemodynamic management of which ODM is a core
constituent is also now becoming widely accepted as an important
major new medical modality. Consequently, the Company's focus is on
maximising value from the opportunities presented as enhanced
haemodynamic management is adopted into routine clinical practice
around the world.
The Company is currently in the implementation phase of
achieving this goal in a number of territories worldwide, operating
directly in the UK, USA, Spain and Canada and through distribution
arrangements in a further 30 countries.
There are over 3,400 monitors installed in hospitals around the
world and around 700,000 patients have been treated to date using
Deltex Medical's single patient disposable probes.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAMMGZKVKKGNZM
(END) Dow Jones Newswires
May 26, 2017 02:01 ET (06:01 GMT)
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From Apr 2024 to May 2024
Deltex Medical (LSE:DEMG)
Historical Stock Chart
From May 2023 to May 2024